<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36615350</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>24</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Molecular Mechanisms of Aggregation of Canine SOD1 E40K Amyloidogenic Mutant Protein.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">156</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules28010156</ELocationID><Abstract><AbstractText>Canine degenerative myelopathy (DM) is a human amyotrophic lateral sclerosis (ALS)-like neurodegenerative disease. It is a unique, naturally occurring animal model of human ALS. Canine DM is associated with the aggregation of canine superoxide dismutase 1 (cSOD1), which is similar to human ALS. Almost 100% of cases in dogs are familial, and the E40K mutation in cSOD1 is a major causative mutation of DM. Therefore, it is important to understand the molecular mechanisms underlying cSOD1(E40K) aggregation. To address this, we first analyzed the structural model of wild type cSOD1. Interactions were evident between amino acid E40 and K91. Therefore, the mutation at residue E40 causes loss of the interaction and may destabilize the native structure of cSOD1. Differential scanning fluorimetry revealed that the E40K mutant was less stable than the wild type. Moreover, stability could be recovered by the E40K and K91E double mutation. Acceleration of amyloid fibril formation in vitro and aggregate formation in cells of cSOD1(E40K) was also suppressed by the introduction of this double mutation in thioflavin T fluorescence assay results and in transfectant cells, respectively. These results clearly show the importance of the interaction between amino acid residues E40 and K91 in cSOD1 for the stability of the native structure and aggregation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wakayama</LastName><ForeName>Kento</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Shintaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Life Science Research Center, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobatake</LastName><ForeName>Yui</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2346-2078</Identifier><AffiliationInfo><Affiliation>Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamishina</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Life Science Research Center, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kyoto AR, 33 Sayama-Nakamichi, Kumiyama, Kuze, Kyoto 613-0036, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishii</LastName><ForeName>Naohito</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takashima</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Ryo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamatari</LastName><ForeName>Yuji O</ForeName><Initials>YO</Initials><Identifier Source="ORCID">0000-0001-9573-5162</Identifier><AffiliationInfo><Affiliation>Life Science Research Center, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Glyco-Core Research (iGCORE), Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP20254740</GrantID><Agency>JSPS KAKENHI</Agency><Country/></Grant><Grant><GrantID>JP20280091</GrantID><Agency>JSPS KAKENHI</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050505">Mutant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050505" MajorTopicYN="N">Mutant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyloidogenic proteins</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">degenerative myelopathy</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">superoxide dismutase 1</Keyword></KeywordList><CoiStatement>The funders had no role in the study design; collection, analyses, or interpretation of data; writing of the manuscript; or decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>8</Day><Hour>1</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36615350</ArticleId><ArticleId IdType="pmc">PMC9822309</ArticleId><ArticleId IdType="doi">10.3390/molecules28010156</ArticleId><ArticleId IdType="pii">molecules28010156</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic Lateral Sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner B.J., Talbot K. Transgenics, Toxicity and Therapeutics in Rodent Models of Mutant SOD1-Mediated Familial ALS. Prog. Neurobiol. 2008;85:94&#x2013;134. doi: 10.1016/j.pneurobio.2008.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2008.01.001</ArticleId><ArticleId IdType="pubmed">18282652</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.-X., et al. Mutations in Cu/Zn Superoxide Dismutase Gene Are Associated with Familial Amyotrophic Lateral Sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Awano T., Johnson G.S., Wade C.M., Katz M.L., Johnson G.C., Taylor J.F., Perloski M., Biagi T., Baranowska I., Long S., et al. Genome-Wide Association Analysis Reveals a SOD1 Mutation in Canine Degenerative Myelopathy That Resembles Amyotrophic Lateral Sclerosis. Proc. Natl. Acad. Sci. USA. 2009;106:2794&#x2013;2799. doi: 10.1073/pnas.0812297106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0812297106</ArticleId><ArticleId IdType="pmc">PMC2634802</ArticleId><ArticleId IdType="pubmed">19188595</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamae S., Kobatake Y., Suzuki R., Tsukui T., Kato S., Yamato O., Sakai H., Urushitani M., Maeda S., Kamishina H. Accumulation and Aggregate Formation of Mutant Superoxide Dismutase 1 in Canine Degenerative Myelopathy. Neuroscience. 2015;303:229&#x2013;240. doi: 10.1016/j.neuroscience.2015.06.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.06.066</ArticleId><ArticleId IdType="pubmed">26162235</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyake K., Kobatake Y., Shibata S., Sakai H., Saito M., Yamato O., Kushida K., Maeda S., Kamishina H. Changes in Respiratory Function in Pembroke Welsh Corgi Dogs with Degenerative Myelopathy. J. Vet. Med. Sci. 2016;78:1323&#x2013;1327. doi: 10.1292/jvms.15-0521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1292/jvms.15-0521</ArticleId><ArticleId IdType="pmc">PMC5053935</ArticleId><ArticleId IdType="pubmed">27109068</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates J.R., March P.A., Oglesbee M., Ruaux C.G., Olby N.J., Berghaus R.D., O&#x2019;Brien D.P., Keating J.H., Johnson G.S., Williams D.A. Clinical Characterization of a Familial Degenerative Myelopathy in Pembroke Welsh Corgi Dogs. J. Vet. Intern. Med. 2007;21:1323&#x2013;1331. doi: 10.1111/j.1939-1676.2007.tb01955.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1939-1676.2007.tb01955.x</ArticleId><ArticleId IdType="pubmed">18196743</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobatake Y., Nakata K., Sakai H., Sasaki J., Yamato O., Takashima S., Nishii N., Maeda S., Islam M.S., Kamishina H. The Long-Term Clinical Course of Canine Degenerative Myelopathy and Therapeutic Potential of Curcumin. Vet. Sci. 2021;8:192. doi: 10.3390/vetsci8090192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vetsci8090192</ArticleId><ArticleId IdType="pmc">PMC8471773</ArticleId><ArticleId IdType="pubmed">34564586</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardone R., H&#xf6;ller Y., Taylor A.C., Lochner P., Tezzon F., Golaszewski S., Brigo F., Trinka E. Canine Degenerative Myelopathy: A Model of Human Amyotrophic Lateral Sclerosis. Zoology. 2016;119:64&#x2013;73. doi: 10.1016/j.zool.2015.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.zool.2015.09.003</ArticleId><ArticleId IdType="pubmed">26432396</ArticleId></ArticleIdList></Reference><Reference><Citation>Coates J.R., Wininger F.A. Canine Degenerative Myelopathy. Vet. Clin. North Am. Small Anim. Pract. 2010;40:929&#x2013;950. doi: 10.1016/j.cvsm.2010.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cvsm.2010.05.001</ArticleId><ArticleId IdType="pubmed">20732599</ArticleId></ArticleIdList></Reference><Reference><Citation>Dion P.A., Daoud H., Rouleau G.A. Genetics of Motor Neuron Disorders: New Insights into Pathogenic Mechanisms. Nat. Rev. Genet. 2009;10:769&#x2013;782. doi: 10.1038/nrg2680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2680</ArticleId><ArticleId IdType="pubmed">19823194</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward C., Brock D.J., Minns R.A., Swingler R.J. Homozygosity for Asn86Ser Mutation in the CuZn-Superoxide Dismutase Gene Produces a Severe Clinical Phenotype in a Juvenile Onset Case of Familial Amyotrophic Lateral Sclerosis. J. Med. Genet. 1998;35:174. doi: 10.1136/jmg.35.2.174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.35.2.174</ArticleId><ArticleId IdType="pmc">PMC1051232</ArticleId><ArticleId IdType="pubmed">9556377</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T., Je G., Pacut P., Keyhanian K., Gao J., Ghasemi M. Gene Therapy in Amyotrophic Lateral Sclerosis. Cells. 2022;11:2066. doi: 10.3390/cells11132066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11132066</ArticleId><ArticleId IdType="pmc">PMC9265980</ArticleId><ArticleId IdType="pubmed">35805149</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Al-Chalabi A. Clinical Genetics of Amyotrophic Lateral Sclerosis: What Do We Really Know? Nat. Rev. Neurol. 2011;7:603&#x2013;615. doi: 10.1038/nrneurol.2011.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.150</ArticleId><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng R., Coates J.R., Johnson G.C., Hansen L., Awano T., Kolicheski A., Ivansson E., Perloski M., Lindblad-Toh K., O&#x2019;Brien D.P., et al. Breed Distribution of SOD1 Alleles Previously Associated with Canine Degenerative Myelopathy. J. Vet. Intern. Med. 2014;28:515&#x2013;521. doi: 10.1111/jvim.12317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvim.12317</ArticleId><ArticleId IdType="pmc">PMC4238831</ArticleId><ArticleId IdType="pubmed">24524809</ArticleId></ArticleIdList></Reference><Reference><Citation>Wininger F.A., Zeng R., Johnson G.S., Katz M.L., Johnson G.C., Bush W.W., Jarboe J.M., Coates J.R. Degenerative Myelopathy in a Bernese Mountain Dog with a Novel SOD1 Missense Mutation. J. Vet. Intern. Med. 2011;25:1166&#x2013;1170. doi: 10.1111/j.1939-1676.2011.0760.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1939-1676.2011.0760.x</ArticleId><ArticleId IdType="pubmed">21848967</ArticleId></ArticleIdList></Reference><Reference><Citation>McCord J.M., Fridovich I. Superoxide Dismutase: An Enzymic Function for Erythrocuprein (Hemocuprein) J. Biol. Chem. 1969;244:6049&#x2013;6055. doi: 10.1016/S0021-9258(18)63504-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)63504-5</ArticleId><ArticleId IdType="pubmed">5389100</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridovich I. Superoxide Radical and the Bactericidal Action of Phagocytes. New Engl. J. Med. 1974;290:624&#x2013;625. doi: 10.1056/NEJM197403142901112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197403142901112</ArticleId><ArticleId IdType="pubmed">4591067</ArticleId></ArticleIdList></Reference><Reference><Citation>Parge H.E., Hallewell R.A., Tainer J.A. Atomic Structures of Wild-Type and Thermostable Mutant Recombinant Human Cu, Zn Superoxide Dismutase. Proc. Natl. Acad. Sci. USA. 1992;89:6109&#x2013;6113. doi: 10.1073/pnas.89.13.6109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.89.13.6109</ArticleId><ArticleId IdType="pmc">PMC49447</ArticleId><ArticleId IdType="pubmed">1463506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogihara N.L., Parge H.E., Hart P.J., Weiss M.S., Goto J.J., Crane B.R., Tsang J., Slater K., Roe J.A., Valentine J.S., et al. Unusual Trigonal-Planar Copper Configuration Revealed in the Atomic Structure of Yeast Copper-Zinc Superoxide Dismutase. Biochemistry. 1996;35:2316&#x2013;2321. doi: 10.1021/bi951930b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi951930b</ArticleId><ArticleId IdType="pubmed">8652572</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart P.J., Balbirnie M.M., Ogihara N.L., Nersissian A.M., Weiss M.S., Valentine J.S., Eisenberg D. A Structure-Based Mechanism for Copper-Zinc Superoxide Dismutase. Biochemistry. 1999;38:2167&#x2013;2178. doi: 10.1021/bi982284u.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi982284u</ArticleId><ArticleId IdType="pubmed">10026301</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S.L., Tolwani R.J., Varma S., Quignon P., Galibert F., Cork L.C. Structure, Chromosomal Location, and Analysis of the Canine Cu/Zn Superoxide Dismutase (SOD1) Gene. J. Hered. 2002;93:119&#x2013;124. doi: 10.1093/jhered/93.2.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jhered/93.2.119</ArticleId><ArticleId IdType="pubmed">12140271</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura S., Kamatari Y.O., Kuwahara Y., Hara H., Yamato O., Maeda S., Kamishina H., Honda R. Canine SOD1 Harboring E40K or T18S Mutations Promotes Protein Aggregation without Reducing the Global Structural Stability. PeerJ. 2020;8:e9512. doi: 10.7717/peerj.9512.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.9512</ArticleId><ArticleId IdType="pmc">PMC7368427</ArticleId><ArticleId IdType="pubmed">32742795</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamatari Y.O., Konno T., Kataoka M., Akasaka K. The Methanol-Induced Globular and Expanded Denatured States of Cytochrome c: A Study by CD Fluorescence, NMR and Small-Angle X-Ray Scattering. J. Mol. Biol. 1996;259:512&#x2013;523. doi: 10.1006/jmbi.1996.0336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1996.0336</ArticleId><ArticleId IdType="pubmed">8676385</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson C.M. Protein Folding. Solid Evidence for Molten Globules. Curr. Biol. 1994;4:636&#x2013;640. doi: 10.1016/S0960-9822(00)00141-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(00)00141-X</ArticleId><ArticleId IdType="pubmed">7953543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwajima K. The Molten Globule State as a Clue for Understanding the Folding and Cooperativity of Globular-Protein Structure. Proteins. 1989;6:87&#x2013;103. doi: 10.1002/prot.340060202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.340060202</ArticleId><ArticleId IdType="pubmed">2695928</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura S., Kamishina H., Hirata Y., Furuta K., Furukawa Y., Yamato O., Maeda S., Kamatari Y.O. Novel oxindole compounds inhibit the aggregation of amyloidogenic proteins associated with neurodegenerative diseases. Biochim. Biophys. Acta Gen. Subj. 2022;1866:130114. doi: 10.1016/j.bbagen.2022.130114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2022.130114</ArticleId><ArticleId IdType="pubmed">35217127</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., O&#x2019;Halloran T.V. Amyotrophic Lateral Sclerosis Mutations Have the Greatest Destabilizing Effect on the Apo- and Reduced Form of SOD1, Leading to Unfolding and Oxidative Aggregation. J. Biol. Chem. 2005;280:17266&#x2013;17274. doi: 10.1074/jbc.M500482200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500482200</ArticleId><ArticleId IdType="pubmed">15691826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart P.J., Liu H., Pellegrini M., Nersissian A.M., Gralla E.B., Valentine J.S., Eisenberg D. Subunit Asymmetry in the Three-Dimensional Structure of a Human CuZnSOD Mutant Found in Familial Amyotrophic Lateral Sclerosis. Protein Sci. 1998;7:545&#x2013;555. doi: 10.1002/pro.5560070302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.5560070302</ArticleId><ArticleId IdType="pmc">PMC2143953</ArticleId><ArticleId IdType="pubmed">9541385</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare S.D., Dokholyan N.V. Common Dynamical Signatures of Familial Amyotrophic Lateral Sclerosis-Associated Structurally Diverse Cu, Zn Superoxide Dismutase Mutants. Proc. Natl. Acad. Sci. USA. 2006;103:3147&#x2013;3152. doi: 10.1073/pnas.0511266103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0511266103</ArticleId><ArticleId IdType="pmc">PMC1413921</ArticleId><ArticleId IdType="pubmed">16488975</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P. Amyotrophic Lateral Sclerosis and Structural Defects in Cu, Zn Superoxide Dismutase. Science. 1993;261:1047&#x2013;1051. doi: 10.1126/science.8351519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8351519</ArticleId><ArticleId IdType="pubmed">8351519</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson J.S., Richardson D.C. Natural Beta-Sheet Proteins Use Negative Design to Avoid Edge-to-Edge Aggregation. Proc. Natl. Acad. Sci. USA. 2002;99:2754&#x2013;2759. doi: 10.1073/pnas.052706099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.052706099</ArticleId><ArticleId IdType="pmc">PMC122420</ArticleId><ArticleId IdType="pubmed">11880627</ArticleId></ArticleIdList></Reference><Reference><Citation>Shipp E.L., Cantini F., Bertini I., Valentine J.S., Banci L. Dynamic Properties of the G93A Mutant of Copper&#x2212;Zinc Superoxide Dismutase as Detected by NMR Spectroscopy:&#x2009; Implications for the Pathology of Familial Amyotrophic Lateral Sclerosis. Biochemistry. 2003;42:1890&#x2013;1899. doi: 10.1021/bi026704y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi026704y</ArticleId><ArticleId IdType="pubmed">12590575</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt D.R., Lee M.K., Slunt H.S., Guarnieri M., Xu Z.S., Wong P.C., Brown R.H., Jr., Price D.L., Sisodia S.S., Cleveland D.W. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA. 1994;91:8292&#x2013;8296. doi: 10.1073/pnas.91.17.8292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.17.8292</ArticleId><ArticleId IdType="pmc">PMC44592</ArticleId><ArticleId IdType="pubmed">8058797</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiti F., Calamai M., Taddei N., Stefani M., Ramponi G., Dobson C.M. Studies of the Aggregation of Mutant Proteins in Vitro Provide Insights into the Genetics of Amyloid Diseases. Proc. Natl. Acad. Sci. USA. 2002;99:16419&#x2013;16426. doi: 10.1073/pnas.212527999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.212527999</ArticleId><ArticleId IdType="pmc">PMC139903</ArticleId><ArticleId IdType="pubmed">12374855</ArticleId></ArticleIdList></Reference><Reference><Citation>Calamai M., Taddei N., Stefani M., Ramponi G., Chiti F. Relative Influence of Hydrophobicity and Net Charge in the Aggregation of Two Homologous Proteins. Biochemistry. 2003;42:15078&#x2013;15083. doi: 10.1021/bi030135s.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi030135s</ArticleId><ArticleId IdType="pubmed">14690417</ArticleId></ArticleIdList></Reference><Reference><Citation>Draper A.C.E., Wilson Z., Maile C., Faccenda D., Campanella M., Piercy R.J. Species-Specific Consequences of an E40K Missense Mutation in Superoxide Dismutase 1 (SOD1) FASEB J. 2020;34:458&#x2013;473. doi: 10.1096/fj.201901455R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201901455R</ArticleId><ArticleId IdType="pubmed">31914665</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L., Bertini I., Boca M., Calderone V., Cantini F., Girotto S., Vieru M. Structural and Dynamic Aspects Related to Oligomerization of Apo SOD1 and Its Mutants. Proc. Natl. Acad. Sci. USA. 2009;106:6980&#x2013;6985. doi: 10.1073/pnas.0809845106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0809845106</ArticleId><ArticleId IdType="pmc">PMC2678485</ArticleId><ArticleId IdType="pubmed">19369197</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>